Therapeutic effect of erythroid differentiation regulator 1 (Erdr1) on collagen-induced arthritis in DBA/1J mouse

Kyung Eun Kim, Sungryung Kim, Sunyoung Park, Younkyung Houh, Yoolhee Yang, Seung Beom Park, Sangyoon Kim, Daejin Kim, Dae Young Hur, Seonghan Kim, Hyun Jeong Park, Sa Ik Bang, Dae Ho Cho

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease, and multiple inflammatory cytokines are involved in RA pathogenesis. Interleukin (IL)-18, in particular, has a significant positive correlation with RA. In this study, we investigated the effect of erythroid differentiation regulator 1 (Erdr1), which is negatively regulated by IL-18, in an animal model of inflammatory arthritis, collageninduced arthritis (CIA) in DBA/1J mice. Treatment of mice with recombinant (r) Erdr1 significantly suppressed the severity of arthritis, histologic features of arthritic tissue, and serum levels of anti-collagen autoantibodies (IgG, IgG1, IgG2a and IgM) in CIA. In addition, IL-18 expression was reduced in the affected synovium of rErdr1-treated mice. Interestingly, Erdr1 treatment suppressed migration in contrast to the pro-migratory effect of IL-18, indicating the therapeutic effects of Erdr1 on CIA through inhibiting synovial fibroblast migration. In addition, Erdr1 inhibited activation of ERK1/2, a key signaling pathway in migration of various cell types. Taken together, these data show that rErdr1 exerts therapeutic effects on RA by inhibiting synovial fibroblast migration, suggesting that rErdr1 treatment might be an effective therapeutic approach for RA.

Original languageEnglish
Pages (from-to)76354-76361
Number of pages8
JournalOncotarget
Volume7
Issue number47
DOIs
Publication statusPublished - 2016 Jan 1
Externally publishedYes

Fingerprint

Inbred DBA Mouse
Experimental Arthritis
Therapeutic Uses
Arthritis
Interleukin-18
Rheumatoid Arthritis
Fibroblasts
Immunoglobulin G
Synovial Membrane
Autoantibodies
Autoimmune Diseases
Cell Movement
Immunoglobulin M
Collagen
Animal Models
Cytokines
Serum

Keywords

  • Erythroid differentiation regulator 1 (Erdr1)
  • Immune response
  • Immunity
  • Immunology and Microbiology Section
  • Inflammation
  • Interleukin-18 (IL-18)
  • Rheumatoid arthritis
  • Synovial fibroblast migration

ASJC Scopus subject areas

  • Oncology

Cite this

Therapeutic effect of erythroid differentiation regulator 1 (Erdr1) on collagen-induced arthritis in DBA/1J mouse. / Kim, Kyung Eun; Kim, Sungryung; Park, Sunyoung; Houh, Younkyung; Yang, Yoolhee; Park, Seung Beom; Kim, Sangyoon; Kim, Daejin; Hur, Dae Young; Kim, Seonghan; Park, Hyun Jeong; Bang, Sa Ik; Cho, Dae Ho.

In: Oncotarget, Vol. 7, No. 47, 01.01.2016, p. 76354-76361.

Research output: Contribution to journalArticle

Kim, KE, Kim, S, Park, S, Houh, Y, Yang, Y, Park, SB, Kim, S, Kim, D, Hur, DY, Kim, S, Park, HJ, Bang, SI & Cho, DH 2016, 'Therapeutic effect of erythroid differentiation regulator 1 (Erdr1) on collagen-induced arthritis in DBA/1J mouse', Oncotarget, vol. 7, no. 47, pp. 76354-76361. https://doi.org/10.18632/oncotarget.13047
Kim, Kyung Eun ; Kim, Sungryung ; Park, Sunyoung ; Houh, Younkyung ; Yang, Yoolhee ; Park, Seung Beom ; Kim, Sangyoon ; Kim, Daejin ; Hur, Dae Young ; Kim, Seonghan ; Park, Hyun Jeong ; Bang, Sa Ik ; Cho, Dae Ho. / Therapeutic effect of erythroid differentiation regulator 1 (Erdr1) on collagen-induced arthritis in DBA/1J mouse. In: Oncotarget. 2016 ; Vol. 7, No. 47. pp. 76354-76361.
@article{d3cf3275a31a4db18d6a3b06df2dbfc9,
title = "Therapeutic effect of erythroid differentiation regulator 1 (Erdr1) on collagen-induced arthritis in DBA/1J mouse",
abstract = "Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease, and multiple inflammatory cytokines are involved in RA pathogenesis. Interleukin (IL)-18, in particular, has a significant positive correlation with RA. In this study, we investigated the effect of erythroid differentiation regulator 1 (Erdr1), which is negatively regulated by IL-18, in an animal model of inflammatory arthritis, collageninduced arthritis (CIA) in DBA/1J mice. Treatment of mice with recombinant (r) Erdr1 significantly suppressed the severity of arthritis, histologic features of arthritic tissue, and serum levels of anti-collagen autoantibodies (IgG, IgG1, IgG2a and IgM) in CIA. In addition, IL-18 expression was reduced in the affected synovium of rErdr1-treated mice. Interestingly, Erdr1 treatment suppressed migration in contrast to the pro-migratory effect of IL-18, indicating the therapeutic effects of Erdr1 on CIA through inhibiting synovial fibroblast migration. In addition, Erdr1 inhibited activation of ERK1/2, a key signaling pathway in migration of various cell types. Taken together, these data show that rErdr1 exerts therapeutic effects on RA by inhibiting synovial fibroblast migration, suggesting that rErdr1 treatment might be an effective therapeutic approach for RA.",
keywords = "Erythroid differentiation regulator 1 (Erdr1), Immune response, Immunity, Immunology and Microbiology Section, Inflammation, Interleukin-18 (IL-18), Rheumatoid arthritis, Synovial fibroblast migration",
author = "Kim, {Kyung Eun} and Sungryung Kim and Sunyoung Park and Younkyung Houh and Yoolhee Yang and Park, {Seung Beom} and Sangyoon Kim and Daejin Kim and Hur, {Dae Young} and Seonghan Kim and Park, {Hyun Jeong} and Bang, {Sa Ik} and Cho, {Dae Ho}",
year = "2016",
month = "1",
day = "1",
doi = "10.18632/oncotarget.13047",
language = "English",
volume = "7",
pages = "76354--76361",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "47",

}

TY - JOUR

T1 - Therapeutic effect of erythroid differentiation regulator 1 (Erdr1) on collagen-induced arthritis in DBA/1J mouse

AU - Kim, Kyung Eun

AU - Kim, Sungryung

AU - Park, Sunyoung

AU - Houh, Younkyung

AU - Yang, Yoolhee

AU - Park, Seung Beom

AU - Kim, Sangyoon

AU - Kim, Daejin

AU - Hur, Dae Young

AU - Kim, Seonghan

AU - Park, Hyun Jeong

AU - Bang, Sa Ik

AU - Cho, Dae Ho

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease, and multiple inflammatory cytokines are involved in RA pathogenesis. Interleukin (IL)-18, in particular, has a significant positive correlation with RA. In this study, we investigated the effect of erythroid differentiation regulator 1 (Erdr1), which is negatively regulated by IL-18, in an animal model of inflammatory arthritis, collageninduced arthritis (CIA) in DBA/1J mice. Treatment of mice with recombinant (r) Erdr1 significantly suppressed the severity of arthritis, histologic features of arthritic tissue, and serum levels of anti-collagen autoantibodies (IgG, IgG1, IgG2a and IgM) in CIA. In addition, IL-18 expression was reduced in the affected synovium of rErdr1-treated mice. Interestingly, Erdr1 treatment suppressed migration in contrast to the pro-migratory effect of IL-18, indicating the therapeutic effects of Erdr1 on CIA through inhibiting synovial fibroblast migration. In addition, Erdr1 inhibited activation of ERK1/2, a key signaling pathway in migration of various cell types. Taken together, these data show that rErdr1 exerts therapeutic effects on RA by inhibiting synovial fibroblast migration, suggesting that rErdr1 treatment might be an effective therapeutic approach for RA.

AB - Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease, and multiple inflammatory cytokines are involved in RA pathogenesis. Interleukin (IL)-18, in particular, has a significant positive correlation with RA. In this study, we investigated the effect of erythroid differentiation regulator 1 (Erdr1), which is negatively regulated by IL-18, in an animal model of inflammatory arthritis, collageninduced arthritis (CIA) in DBA/1J mice. Treatment of mice with recombinant (r) Erdr1 significantly suppressed the severity of arthritis, histologic features of arthritic tissue, and serum levels of anti-collagen autoantibodies (IgG, IgG1, IgG2a and IgM) in CIA. In addition, IL-18 expression was reduced in the affected synovium of rErdr1-treated mice. Interestingly, Erdr1 treatment suppressed migration in contrast to the pro-migratory effect of IL-18, indicating the therapeutic effects of Erdr1 on CIA through inhibiting synovial fibroblast migration. In addition, Erdr1 inhibited activation of ERK1/2, a key signaling pathway in migration of various cell types. Taken together, these data show that rErdr1 exerts therapeutic effects on RA by inhibiting synovial fibroblast migration, suggesting that rErdr1 treatment might be an effective therapeutic approach for RA.

KW - Erythroid differentiation regulator 1 (Erdr1)

KW - Immune response

KW - Immunity

KW - Immunology and Microbiology Section

KW - Inflammation

KW - Interleukin-18 (IL-18)

KW - Rheumatoid arthritis

KW - Synovial fibroblast migration

UR - http://www.scopus.com/inward/record.url?scp=84998773606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84998773606&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.13047

DO - 10.18632/oncotarget.13047

M3 - Article

C2 - 27823968

AN - SCOPUS:84998773606

VL - 7

SP - 76354

EP - 76361

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 47

ER -